旅橙文化(08627.HK)預計中期由盈轉虧不超300萬元
格隆匯8月5日丨旅橙文化(08627.HK)發佈公告,公司預期截至2020年6月30日止6個月將錄得不超過人民幣300萬元的淨虧損,上年同期純利約人民幣430萬元。淨虧損主要由於爆發新型冠狀病毒(COVID-19)疫情引致集團營銷服務新合約需求減少及集團現有項目遭延遲或取消,導致集團期間收入較2019年同期減少超過70%;及期間由於僱員人數增加而導致員工福利開支增加。疫情已對整體經濟狀況產生不利影響,而目前市場情緒低迷。由於疫情可能會持續一段時間,因此,疫情會對集團業務及財務表現產生影響的程度仍有待釐定。董事會正密切監察現時的情況,並會尋求適當的措施以減低疫情對集團的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.